Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-014698
Filing Date
2020-03-02
Accepted
2020-03-02 17:56:48
Documents
1
Period of Report
2020-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4041
  Complete submission text file 0001209191-20-014698.txt   5469
Mailing Address 450 WEST 15 STREET SUITE 505 NEW YORK NY 10011
Business Address
Kapadia Sandip (Reporting) CIK: 0001677141 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39231 | Film No.: 20678788

Mailing Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103
Business Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Issuer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)